Home > Product > Ibandronate TAB
| CATEGORY |
PRODUCT PROFILE |
DRUG NAME
|
Ibandronate Tablet
(168.75mg as Ibandronate sodium monohydrate, 150mg as Ibandronic acid)
|
| COMPANY |
Biopharmartis(BP) : subsidiary of Hyundai Pharm. Group
|
DEVELOPMENT
STATUS |
Launched in August, 2012
|
| THERAPY AREA |
Prevention & treatment of women's osteoporosis after menopause
|
DOSAGE & USAGE
Bio Availability
|
One tablet per month in the morning time
0.6%
|
TMAX / HALF-LIFE
|
Tmax < 1hour / 10 to 60 hrs
|
